These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33104975)
1. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer. Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975 [TBL] [Abstract][Full Text] [Related]
2. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States. Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052 [TBL] [Abstract][Full Text] [Related]
3. Associations of thiazide use with skin cancers: a systematic review and meta-analysis. Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547 [TBL] [Abstract][Full Text] [Related]
4. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study. de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493 [TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346 [TBL] [Abstract][Full Text] [Related]
6. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study. Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW; J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517 [TBL] [Abstract][Full Text] [Related]
7. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea. Park E; Lee Y; Jue MS Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528 [TBL] [Abstract][Full Text] [Related]
8. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity. Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540 [TBL] [Abstract][Full Text] [Related]
9. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population? Carney K; Cousins M Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330 [TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibitors show no preventive effect in the development of skin cancer. Yen H; Yen H; Drucker AM; Han J; Li WQ; Li T; Qureshi A; Cho E J Dtsch Dermatol Ges; 2022 Feb; 20(2):157-166. PubMed ID: 35088518 [TBL] [Abstract][Full Text] [Related]
11. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105 [TBL] [Abstract][Full Text] [Related]
12. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies. Morales DR; Pacurariu A; Slattery J; Kurz X Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906 [TBL] [Abstract][Full Text] [Related]
13. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study. Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085 [TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677 [TBL] [Abstract][Full Text] [Related]
15. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study. Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261 [TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L J Am Heart Assoc; 2022 Dec; 11(24):e026789. PubMed ID: 36515246 [TBL] [Abstract][Full Text] [Related]
18. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study. Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer. Lian Y; Yin H; Pollak MN; Carrier S; Platt RW; Suissa S; Azoulay L Eur Urol; 2016 Nov; 70(5):808-815. PubMed ID: 27178449 [TBL] [Abstract][Full Text] [Related]
20. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma. Pottegård A; Pedersen SA; Schmidt SAJ; Hölmich LR; Friis S; Gaist D JAMA Intern Med; 2018 Aug; 178(8):1120-1122. PubMed ID: 29813157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]